Tapentadol: an overview of the safety profile.
Polati E, Canonico PL, Schweiger V, Collino M.
Polati E, et al.
J Pain Res. 2019 May 16;12:1569-1576. doi: 10.2147/JPR.S190154. eCollection 2019.
J Pain Res. 2019.
PMID: 31190968
Free PMC article.
Review.
Noteworthy, MOR activation with tapentadol is markedly lower compared with that exerted by classical opioids, thus likely resulting in fewer opioid-related adverse effects. In this review, we discuss current safety data on tapentadol, with a focus on some specific e …
Noteworthy, MOR activation with tapentadol is markedly lower compared with that exerted by classical opioids, thus likely resulting i …